Nature Communications (Jun 2021)
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
- Xuping Xie,
- Antonio E. Muruato,
- Xianwen Zhang,
- Kumari G. Lokugamage,
- Camila R. Fontes-Garfias,
- Jing Zou,
- Jianying Liu,
- Ping Ren,
- Mini Balakrishnan,
- Tomas Cihlar,
- Chien-Te K. Tseng,
- Shinji Makino,
- Vineet D. Menachery,
- John P. Bilello,
- Pei-Yong Shi
Affiliations
- Xuping Xie
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
- Antonio E. Muruato
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
- Xianwen Zhang
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
- Kumari G. Lokugamage
- Department of Microbiology and Immunology, University of Texas Medical Branch
- Camila R. Fontes-Garfias
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
- Jing Zou
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
- Jianying Liu
- Department of Microbiology and Immunology, University of Texas Medical Branch
- Ping Ren
- Department of Pathology, University of Texas Medical Branch
- Mini Balakrishnan
- Gilead Sciences, Inc.
- Tomas Cihlar
- Gilead Sciences, Inc.
- Chien-Te K. Tseng
- Department of Microbiology and Immunology, University of Texas Medical Branch
- Shinji Makino
- Department of Microbiology and Immunology, University of Texas Medical Branch
- Vineet D. Menachery
- Department of Microbiology and Immunology, University of Texas Medical Branch
- John P. Bilello
- Gilead Sciences, Inc.
- Pei-Yong Shi
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
- DOI
- https://doi.org/10.1038/s41467-021-24300-8
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
